Neuberger Berman Group »

Atea Pharmaceuticals shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $56k 12k 4.65

More positions owned by Neuberger Berman Group

Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Microsoft Corp Common (MSFT)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Jpmorgan Chase & Co Common (JPM)
Eli Lilly & Co Common (LLY)
Ishares Core S&p 500 Etf Etf (IVV)
Broadcom Common (AVGO)
Asml Holding Adr Representing Nv Common (ASML)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Nextera Energy Common (NEE)
Analog Devices Common (ADI)

View all positions for Neuberger Berman Group

Top funds holding Atea Pharmaceuticals

FMR
BlackRock
BML Capital Management
Tang Capital Management
Vanguard Capital Management
Bain Capital Life Sciences Investors
Acadian Asset Management
Geode Capital Management
State Street Corporation
Two Sigma Investments
Dimensional Fund Advisors
Renaissance Technologies
Rosalind Advisors
Jpmorgan Chase & Co
Northern Trust

View all funds holding Atea Pharmaceuticals